Global pharmaceuticals: ethics, markets, practices
In some parts of the world spending on pharmaceuticals is astronomical. In others people do not have access to basic or life-saving drugs. Individuals struggle to afford medications; whole populations are neglected, considered too poor to constitute profitable markets for the development and distrib...
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Durham [u.a.]
Duke Univ. Press
2006
|
| Schlagworte: | |
| Online-Zugang: | Table of contents Inhaltsverzeichnis |
| Zusammenfassung: | In some parts of the world spending on pharmaceuticals is astronomical. In others people do not have access to basic or life-saving drugs. Individuals struggle to afford medications; whole populations are neglected, considered too poor to constitute profitable markets for the development and distribution of necessary drugs. The ethnographies brought together in this timely collection analyze both the dynamics of the burgeoning international pharmaceutical trade and the global inequalities that emerge from and are reinforced by market-driven medicine. They demonstrate that questions about who will be treated and who will not filter through every phase of pharmaceutical production, from preclinical research to human testing, marketing, distribution, prescription, and consumption. Whether considering how American drug companies seek to create a market for antidepressants in Japan, how Brazil has created a model HIV/AIDS prevention and treatment program, or how the urban poor in Delhi understand and access healthcare, these essays illuminate the roles of corporations, governments, NGOs, and individuals in relation to global pharmaceuticals. |
| Beschreibung: | Includes bibliographical references and index |
| Beschreibung: | 301 S. Ill. |
| ISBN: | 0822337290 082233741X |
Internformat
MARC
| LEADER | 00000nam a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV021528798 | ||
| 003 | DE-604 | ||
| 005 | 20060905 | ||
| 007 | t | ||
| 008 | 060328s2006 xxua||| |||| 00||| eng d | ||
| 010 | |a 2005028222 | ||
| 020 | |a 0822337290 |c cloth : alk. paper |9 0-8223-3729-0 | ||
| 020 | |a 082233741X |c pbk. : alk. paper |9 0-8223-3741-X | ||
| 035 | |a (OCoLC)61731434 | ||
| 035 | |a (DE-599)BVBBV021528798 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 044 | |a xxu |c US | ||
| 049 | |a DE-703 |a DE-12 |a DE-19 |a DE-11 |a DE-188 | ||
| 050 | 0 | |a HD9665.5 | |
| 082 | 0 | |a 338.4/76151 |2 22 | |
| 084 | |a QR 525 |0 (DE-625)142044: |2 rvk | ||
| 245 | 1 | 0 | |a Global pharmaceuticals |b ethics, markets, practices |c ed. by Adriana Petryna ... |
| 264 | 1 | |a Durham [u.a.] |b Duke Univ. Press |c 2006 | |
| 300 | |a 301 S. |b Ill. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 500 | |a Includes bibliographical references and index | ||
| 520 | 3 | |a In some parts of the world spending on pharmaceuticals is astronomical. In others people do not have access to basic or life-saving drugs. Individuals struggle to afford medications; whole populations are neglected, considered too poor to constitute profitable markets for the development and distribution of necessary drugs. The ethnographies brought together in this timely collection analyze both the dynamics of the burgeoning international pharmaceutical trade and the global inequalities that emerge from and are reinforced by market-driven medicine. They demonstrate that questions about who will be treated and who will not filter through every phase of pharmaceutical production, from preclinical research to human testing, marketing, distribution, prescription, and consumption. Whether considering how American drug companies seek to create a market for antidepressants in Japan, how Brazil has created a model HIV/AIDS prevention and treatment program, or how the urban poor in Delhi understand and access healthcare, these essays illuminate the roles of corporations, governments, NGOs, and individuals in relation to global pharmaceuticals. | |
| 650 | 7 | |a Farmaceutische industrie |2 gtt | |
| 650 | 4 | |a Industrie pharmaceutique | |
| 650 | 4 | |a Industrie pharmaceutique - Marketing | |
| 650 | 7 | |a Internationalisatie |2 gtt | |
| 650 | 7 | |a Marketing |2 gtt | |
| 650 | 7 | |a Medische ethiek |2 gtt | |
| 650 | 4 | |a Médicaments - Commercialisation - Aspect moral | |
| 650 | 4 | |a Pharmaciens - Déontologie | |
| 650 | 4 | |a Ethik | |
| 650 | 4 | |a Globalisierung | |
| 650 | 4 | |a Pharmaceutical industry | |
| 650 | 4 | |a Pharmaceutical industry |x Marketing | |
| 650 | 4 | |a Drugs |x Marketing |x Moral and ethical aspects | |
| 650 | 4 | |a Pharmaceutical ethics | |
| 650 | 4 | |a Drug Industry |x ethics | |
| 650 | 4 | |a Drug Industry |x economics | |
| 650 | 4 | |a Marketing |x ethics | |
| 650 | 4 | |a Commerce | |
| 650 | 4 | |a Health Services Accessibility | |
| 650 | 4 | |a Internationality | |
| 650 | 4 | |a Socioeconomic Factors | |
| 650 | 0 | 7 | |a Internationales Management |0 (DE-588)4114040-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittelversorgung |0 (DE-588)4140783-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittelmarkt |0 (DE-588)4003131-7 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Sozialethik |0 (DE-588)4055765-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Pharmazeutische Industrie |0 (DE-588)4045696-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Gesundheitspolitik |0 (DE-588)4113743-7 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Wirtschaftsethik |0 (DE-588)4066439-9 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
| 689 | 0 | 0 | |a Pharmazeutische Industrie |0 (DE-588)4045696-1 |D s |
| 689 | 0 | 1 | |a Wirtschaftsethik |0 (DE-588)4066439-9 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Arzneimittelmarkt |0 (DE-588)4003131-7 |D s |
| 689 | 1 | 1 | |a Sozialethik |0 (DE-588)4055765-0 |D s |
| 689 | 1 | |5 DE-604 | |
| 689 | 2 | 0 | |a Pharmazeutische Industrie |0 (DE-588)4045696-1 |D s |
| 689 | 2 | 1 | |a Internationales Management |0 (DE-588)4114040-0 |D s |
| 689 | 2 | 2 | |a Arzneimittelmarkt |0 (DE-588)4003131-7 |D s |
| 689 | 2 | 3 | |a Arzneimittelversorgung |0 (DE-588)4140783-0 |D s |
| 689 | 2 | 4 | |a Gesundheitspolitik |0 (DE-588)4113743-7 |D s |
| 689 | 2 | 5 | |a Wirtschaftsethik |0 (DE-588)4066439-9 |D s |
| 689 | 2 | 6 | |a Sozialethik |0 (DE-588)4055765-0 |D s |
| 689 | 2 | |5 DE-188 | |
| 700 | 1 | |a Petryna, Adriana |e Sonstige |4 oth | |
| 856 | 4 | |u http://www.loc.gov/catdir/toc/ecip061/2005028222.html |3 Table of contents | |
| 856 | 4 | 2 | |m HBZ Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=014745175&sequence=000004&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-014745175 | ||
Datensatz im Suchindex
| _version_ | 1804135274112876544 |
|---|---|
| adam_text | CONTENTS
vii Acknowledgments
1 The Pharmaceutical Nexus
ADRIANA PETRYNA AND ARTHUR KLEINMAN
33 Globalizing Human Subjects Research
ADRIANA PETRYNA
61 The New Medical Oikumene
DAVID HEALY
85 Educating for Global Mental Health: The Adoption of SSRIs in Japan
KALMAN APPLBAUM
111 High Contact: Gifts and Surveillance in Argentina
ANDREW LAKOFF
136 Addiction Markets: The Case of High Dose Buprenorphine in France
ANNE M. LOVELL
171 Pharmaceuticals in Urban Ecologies: The Register of the Local
VEENA DAS AND RANENDRA K. DAS
206 Pharmaceutical Governance
JOAO BIEHL
240 Treating AIDS: Dilemmas of Unequal Access in Uganda
SUSAN REYNOLDS WHYTE, MICHAEL A. WHYTE,
LOTTE MEINERT, AND BETTY KYADDONDO
263 References
289 Contributors
291 Index
|
| adam_txt |
CONTENTS
vii Acknowledgments
1 The Pharmaceutical Nexus
ADRIANA PETRYNA AND ARTHUR KLEINMAN
33 Globalizing Human Subjects Research
ADRIANA PETRYNA
61 The New Medical Oikumene
DAVID HEALY
85 Educating for Global Mental Health: The Adoption of SSRIs in Japan
KALMAN APPLBAUM
111 High Contact: Gifts and Surveillance in Argentina
ANDREW LAKOFF
136 Addiction Markets: The Case of High Dose Buprenorphine in France
ANNE M. LOVELL
171 Pharmaceuticals in Urban Ecologies: The Register of the Local
VEENA DAS AND RANENDRA K. DAS
206 Pharmaceutical Governance
JOAO BIEHL
240 Treating AIDS: Dilemmas of Unequal Access in Uganda
SUSAN REYNOLDS WHYTE, MICHAEL A. WHYTE,
LOTTE MEINERT, AND BETTY KYADDONDO
263 References
289 Contributors
291 Index |
| any_adam_object | 1 |
| any_adam_object_boolean | 1 |
| building | Verbundindex |
| bvnumber | BV021528798 |
| callnumber-first | H - Social Science |
| callnumber-label | HD9665 |
| callnumber-raw | HD9665.5 |
| callnumber-search | HD9665.5 |
| callnumber-sort | HD 49665.5 |
| callnumber-subject | HD - Industries, Land Use, Labor |
| classification_rvk | QR 525 |
| ctrlnum | (OCoLC)61731434 (DE-599)BVBBV021528798 |
| dewey-full | 338.4/76151 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 338 - Production |
| dewey-raw | 338.4/76151 |
| dewey-search | 338.4/76151 |
| dewey-sort | 3338.4 576151 |
| dewey-tens | 330 - Economics |
| discipline | Wirtschaftswissenschaften |
| discipline_str_mv | Wirtschaftswissenschaften |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04666nam a2200889zc 4500</leader><controlfield tag="001">BV021528798</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20060905 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">060328s2006 xxua||| |||| 00||| eng d</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="a">2005028222</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0822337290</subfield><subfield code="c">cloth : alk. paper</subfield><subfield code="9">0-8223-3729-0</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">082233741X</subfield><subfield code="c">pbk. : alk. paper</subfield><subfield code="9">0-8223-3741-X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)61731434</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV021528798</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">xxu</subfield><subfield code="c">US</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-703</subfield><subfield code="a">DE-12</subfield><subfield code="a">DE-19</subfield><subfield code="a">DE-11</subfield><subfield code="a">DE-188</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">HD9665.5</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">338.4/76151</subfield><subfield code="2">22</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">QR 525</subfield><subfield code="0">(DE-625)142044:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Global pharmaceuticals</subfield><subfield code="b">ethics, markets, practices</subfield><subfield code="c">ed. by Adriana Petryna ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Durham [u.a.]</subfield><subfield code="b">Duke Univ. Press</subfield><subfield code="c">2006</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">301 S.</subfield><subfield code="b">Ill.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="520" ind1="3" ind2=" "><subfield code="a">In some parts of the world spending on pharmaceuticals is astronomical. In others people do not have access to basic or life-saving drugs. Individuals struggle to afford medications; whole populations are neglected, considered too poor to constitute profitable markets for the development and distribution of necessary drugs. The ethnographies brought together in this timely collection analyze both the dynamics of the burgeoning international pharmaceutical trade and the global inequalities that emerge from and are reinforced by market-driven medicine. They demonstrate that questions about who will be treated and who will not filter through every phase of pharmaceutical production, from preclinical research to human testing, marketing, distribution, prescription, and consumption. Whether considering how American drug companies seek to create a market for antidepressants in Japan, how Brazil has created a model HIV/AIDS prevention and treatment program, or how the urban poor in Delhi understand and access healthcare, these essays illuminate the roles of corporations, governments, NGOs, and individuals in relation to global pharmaceuticals.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Farmaceutische industrie</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Industrie pharmaceutique</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Industrie pharmaceutique - Marketing</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Internationalisatie</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Marketing</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Medische ethiek</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Médicaments - Commercialisation - Aspect moral</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaciens - Déontologie</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Ethik</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Globalisierung</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical industry</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical industry</subfield><subfield code="x">Marketing</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Marketing</subfield><subfield code="x">Moral and ethical aspects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical ethics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Industry</subfield><subfield code="x">ethics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Industry</subfield><subfield code="x">economics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Marketing</subfield><subfield code="x">ethics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Commerce</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Health Services Accessibility</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Internationality</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Socioeconomic Factors</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Internationales Management</subfield><subfield code="0">(DE-588)4114040-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelversorgung</subfield><subfield code="0">(DE-588)4140783-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelmarkt</subfield><subfield code="0">(DE-588)4003131-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Sozialethik</subfield><subfield code="0">(DE-588)4055765-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmazeutische Industrie</subfield><subfield code="0">(DE-588)4045696-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Gesundheitspolitik</subfield><subfield code="0">(DE-588)4113743-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Wirtschaftsethik</subfield><subfield code="0">(DE-588)4066439-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Pharmazeutische Industrie</subfield><subfield code="0">(DE-588)4045696-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Wirtschaftsethik</subfield><subfield code="0">(DE-588)4066439-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Arzneimittelmarkt</subfield><subfield code="0">(DE-588)4003131-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Sozialethik</subfield><subfield code="0">(DE-588)4055765-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Pharmazeutische Industrie</subfield><subfield code="0">(DE-588)4045696-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Internationales Management</subfield><subfield code="0">(DE-588)4114040-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="2"><subfield code="a">Arzneimittelmarkt</subfield><subfield code="0">(DE-588)4003131-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="3"><subfield code="a">Arzneimittelversorgung</subfield><subfield code="0">(DE-588)4140783-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="4"><subfield code="a">Gesundheitspolitik</subfield><subfield code="0">(DE-588)4113743-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="5"><subfield code="a">Wirtschaftsethik</subfield><subfield code="0">(DE-588)4066439-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="6"><subfield code="a">Sozialethik</subfield><subfield code="0">(DE-588)4055765-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="5">DE-188</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Petryna, Adriana</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2=" "><subfield code="u">http://www.loc.gov/catdir/toc/ecip061/2005028222.html</subfield><subfield code="3">Table of contents</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=014745175&sequence=000004&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-014745175</subfield></datafield></record></collection> |
| genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content |
| genre_facet | Aufsatzsammlung |
| id | DE-604.BV021528798 |
| illustrated | Illustrated |
| index_date | 2024-07-02T14:24:40Z |
| indexdate | 2024-07-09T20:37:54Z |
| institution | BVB |
| isbn | 0822337290 082233741X |
| language | English |
| lccn | 2005028222 |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-014745175 |
| oclc_num | 61731434 |
| open_access_boolean | |
| owner | DE-703 DE-12 DE-19 DE-BY-UBM DE-11 DE-188 |
| owner_facet | DE-703 DE-12 DE-19 DE-BY-UBM DE-11 DE-188 |
| physical | 301 S. Ill. |
| publishDate | 2006 |
| publishDateSearch | 2006 |
| publishDateSort | 2006 |
| publisher | Duke Univ. Press |
| record_format | marc |
| spelling | Global pharmaceuticals ethics, markets, practices ed. by Adriana Petryna ... Durham [u.a.] Duke Univ. Press 2006 301 S. Ill. txt rdacontent n rdamedia nc rdacarrier Includes bibliographical references and index In some parts of the world spending on pharmaceuticals is astronomical. In others people do not have access to basic or life-saving drugs. Individuals struggle to afford medications; whole populations are neglected, considered too poor to constitute profitable markets for the development and distribution of necessary drugs. The ethnographies brought together in this timely collection analyze both the dynamics of the burgeoning international pharmaceutical trade and the global inequalities that emerge from and are reinforced by market-driven medicine. They demonstrate that questions about who will be treated and who will not filter through every phase of pharmaceutical production, from preclinical research to human testing, marketing, distribution, prescription, and consumption. Whether considering how American drug companies seek to create a market for antidepressants in Japan, how Brazil has created a model HIV/AIDS prevention and treatment program, or how the urban poor in Delhi understand and access healthcare, these essays illuminate the roles of corporations, governments, NGOs, and individuals in relation to global pharmaceuticals. Farmaceutische industrie gtt Industrie pharmaceutique Industrie pharmaceutique - Marketing Internationalisatie gtt Marketing gtt Medische ethiek gtt Médicaments - Commercialisation - Aspect moral Pharmaciens - Déontologie Ethik Globalisierung Pharmaceutical industry Pharmaceutical industry Marketing Drugs Marketing Moral and ethical aspects Pharmaceutical ethics Drug Industry ethics Drug Industry economics Marketing ethics Commerce Health Services Accessibility Internationality Socioeconomic Factors Internationales Management (DE-588)4114040-0 gnd rswk-swf Arzneimittelversorgung (DE-588)4140783-0 gnd rswk-swf Arzneimittelmarkt (DE-588)4003131-7 gnd rswk-swf Sozialethik (DE-588)4055765-0 gnd rswk-swf Pharmazeutische Industrie (DE-588)4045696-1 gnd rswk-swf Gesundheitspolitik (DE-588)4113743-7 gnd rswk-swf Wirtschaftsethik (DE-588)4066439-9 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content Pharmazeutische Industrie (DE-588)4045696-1 s Wirtschaftsethik (DE-588)4066439-9 s DE-604 Arzneimittelmarkt (DE-588)4003131-7 s Sozialethik (DE-588)4055765-0 s Internationales Management (DE-588)4114040-0 s Arzneimittelversorgung (DE-588)4140783-0 s Gesundheitspolitik (DE-588)4113743-7 s DE-188 Petryna, Adriana Sonstige oth http://www.loc.gov/catdir/toc/ecip061/2005028222.html Table of contents HBZ Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=014745175&sequence=000004&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Global pharmaceuticals ethics, markets, practices Farmaceutische industrie gtt Industrie pharmaceutique Industrie pharmaceutique - Marketing Internationalisatie gtt Marketing gtt Medische ethiek gtt Médicaments - Commercialisation - Aspect moral Pharmaciens - Déontologie Ethik Globalisierung Pharmaceutical industry Pharmaceutical industry Marketing Drugs Marketing Moral and ethical aspects Pharmaceutical ethics Drug Industry ethics Drug Industry economics Marketing ethics Commerce Health Services Accessibility Internationality Socioeconomic Factors Internationales Management (DE-588)4114040-0 gnd Arzneimittelversorgung (DE-588)4140783-0 gnd Arzneimittelmarkt (DE-588)4003131-7 gnd Sozialethik (DE-588)4055765-0 gnd Pharmazeutische Industrie (DE-588)4045696-1 gnd Gesundheitspolitik (DE-588)4113743-7 gnd Wirtschaftsethik (DE-588)4066439-9 gnd |
| subject_GND | (DE-588)4114040-0 (DE-588)4140783-0 (DE-588)4003131-7 (DE-588)4055765-0 (DE-588)4045696-1 (DE-588)4113743-7 (DE-588)4066439-9 (DE-588)4143413-4 |
| title | Global pharmaceuticals ethics, markets, practices |
| title_auth | Global pharmaceuticals ethics, markets, practices |
| title_exact_search | Global pharmaceuticals ethics, markets, practices |
| title_exact_search_txtP | Global pharmaceuticals ethics, markets, practices |
| title_full | Global pharmaceuticals ethics, markets, practices ed. by Adriana Petryna ... |
| title_fullStr | Global pharmaceuticals ethics, markets, practices ed. by Adriana Petryna ... |
| title_full_unstemmed | Global pharmaceuticals ethics, markets, practices ed. by Adriana Petryna ... |
| title_short | Global pharmaceuticals |
| title_sort | global pharmaceuticals ethics markets practices |
| title_sub | ethics, markets, practices |
| topic | Farmaceutische industrie gtt Industrie pharmaceutique Industrie pharmaceutique - Marketing Internationalisatie gtt Marketing gtt Medische ethiek gtt Médicaments - Commercialisation - Aspect moral Pharmaciens - Déontologie Ethik Globalisierung Pharmaceutical industry Pharmaceutical industry Marketing Drugs Marketing Moral and ethical aspects Pharmaceutical ethics Drug Industry ethics Drug Industry economics Marketing ethics Commerce Health Services Accessibility Internationality Socioeconomic Factors Internationales Management (DE-588)4114040-0 gnd Arzneimittelversorgung (DE-588)4140783-0 gnd Arzneimittelmarkt (DE-588)4003131-7 gnd Sozialethik (DE-588)4055765-0 gnd Pharmazeutische Industrie (DE-588)4045696-1 gnd Gesundheitspolitik (DE-588)4113743-7 gnd Wirtschaftsethik (DE-588)4066439-9 gnd |
| topic_facet | Farmaceutische industrie Industrie pharmaceutique Industrie pharmaceutique - Marketing Internationalisatie Marketing Medische ethiek Médicaments - Commercialisation - Aspect moral Pharmaciens - Déontologie Ethik Globalisierung Pharmaceutical industry Pharmaceutical industry Marketing Drugs Marketing Moral and ethical aspects Pharmaceutical ethics Drug Industry ethics Drug Industry economics Marketing ethics Commerce Health Services Accessibility Internationality Socioeconomic Factors Internationales Management Arzneimittelversorgung Arzneimittelmarkt Sozialethik Pharmazeutische Industrie Gesundheitspolitik Wirtschaftsethik Aufsatzsammlung |
| url | http://www.loc.gov/catdir/toc/ecip061/2005028222.html http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=014745175&sequence=000004&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT petrynaadriana globalpharmaceuticalsethicsmarketspractices |